Home
Search results “Memorial sloan kettering papillary thyroid cancer”
Lymph Nodes in Thyroid Cancer -- Sloan-Kettering
 
04:47
Unlike in many other cancers, the spread of thyroid cancer to the lymph nodes has very little impact on survival in most patients, say thyroid cancer experts at Memorial Sloan-Kettering Cancer Center. Lymph nodes that look suspicious may be removed during thyroid surgery, but in most cases, this does not affect the outcome of treatment. For more information, please visit http://www.mskcc.org/thyroidcancer
Experts Discuss Thyroid Cancer Questions | Memorial Sloan Kettering
 
23:32
For more information on thyroid cancer, please visit http://www.mskcc.org/thyroidcancer Like us on Facebook: http://www.facebook.com/sloankettering Follow us on Twitter: http://twitter.com/sloan_kettering Physicians at Memorial Sloan Kettering Cancer Center answer a variety of questions such as risk factors for thyroid cancer, frequency of locally recurrent disease after initial treatment, the importance of experience in using and interpreting imaging data, side effects of radioactive iodine, clinical trials for thyroid cancers that do not respond to radioactive iodine, and the shift toward individualized treatment. {partial transcript} This is a very active area of investigation that has really seen the fruits of its labor over the past five to ten years. Even with more aggressive cancer, there are a lot of reasons to be optimistic? There is much more hope now than there was ten years ago. You talked a bit about before about folks of a certain age receiving radiation therapy for tumors that turned out to be benign. For instance, in children, the thymus gland was enlarged and it turned out to be normally enlarged. Unfortunately, we thought that was bad and a certain population of people ended up with thyroid cancer, secondary to their radiation therapy. Can we talk about risk factors for thyroid cancer and if there’s anything that we can do to avoid some of these risk factors? I’m not sure about how to avoid it, but regarding radiation, there is quite a bit of radiation from the diagnostic imaging in our general population….
Advances in Thyroid Cancer Treatment -- Sloan-Kettering
 
17:20
Memorial Sloan-Kettering Cancer Center specialists in endocrinology, surgery, and radiology discuss the latest approaches to diagnosing and treating thyroid cancer, and reducing the risk of recurrence. For more information, please visit http://www.mskcc.org/thyroidcancer.
Management and Follow-up of High Risk Patients with Papillary Thyroid Cancer
 
34:20
Management and Follow-up of High Risk Patients with Papillary Thyroid Cancer -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA *** מוגש כשירות לציבור הגולשים והגולשות בלבד ואינו מהווה תחליף כלשהו לייעוץ רפואי אישי ופרטני ***
Views: 2110 Rambam Pro
Thyroid Cancer Surgery -- Sloan-Kettering
 
08:20
Surgical oncologist Ashok Shaha of Memorial Sloan-Kettering Cancer Center discusses surgery for patients with a thyroid tumor. In some cases, tests clearly indicate whether surgery is necessary, but in others it may not be clear whether a tumor is malignant (cancerous) or benign (noncancerous). The decision to perform thyroid surgery for these patients depends on the patient's age and sex, as well as the size or growth rate of the tumor. Side effects of thyroid surgery may include hoarseness or other vocal changes, says Dr. Shaha. For more information, please visit http://www.mskcc.org/thyroidcancer
Small Thyroid Cancers, Thyroid Hormones, and More.
 
11:47
In this 12-minute video interview, R. Michael Tuttle, M.D., Endocrinologist at Memorial Sloan-Kettering Cancer Center in New York, New York, discusses several thyroid cancer topics. These include recent research on “watchful waiting” (also called active surveillance) rather than immediate surgery for small papillary or follicular thyroid cancers —under 1 centimeter in size. The interview also covers thyroid hormone replacement decision-making in thyroid cancer patients, as well as the issues of overdiagnosis and overtreatment. Dr. Tuttle is a thyroid cancer specialist, focusing on treatment of advanced thyroid cancer. He is a ThyCa Medical Advisor.
Staging Thyroid Cancer and Residual Disease -- Sloan-Kettering
 
07:59
Diagnostic tools have become so sensitive that they can detect even the tiniest amount of thyroid cancer cells that remain after treatment. But just because doctors find some thyroid cancer cells does not always mean that additional treatment is necessary, say specialists at Memorial Sloan-Kettering Cancer Center, because they may not pose a significant threat to a patient's health. The side effects and costs of treatment must be considered carefully before treating these residual tumors. For more information, please visit http://www.mskcc.org/thyroidcancer
Endoscopic total thyroidectomy with node dissection for papillary thyroid cancer
 
08:21
This video demonstrates the technique of total thyroid excision with lymph node removal for papillary thyroid cancer.
Views: 51406 MountSinaiMEMIS
Endoscopic transaxillary total thyroidectomy for papillary thyroid cancer
 
01:07
Dr Inabnet and his team are now performing endoscopic transaxillary total thyroidectomy for patients with Stage 1 (small) papillary thyroid cancer. With this approach, the incision is placed in the axilla (under the arm pit) which avoids a scar on the neck. The entire thyroid gland can be safely removed and if necessary the central lymph nodes can be removed using the same approach (as demonstrated in this video). This patient was discharged from the hospital the same day of her surgery.
Views: 3270 MountSinaiMEMIS
Diagnosing Thyroid Cancer -- Sloan-Kettering
 
03:28
Radiologist Lucy Hann of Memorial Sloan-Kettering Cancer Center explains how ultrasound is used to determine whether a thyroid tumor is benign (noncancerous) or malignant (cancerous). Features such as the amount of calcification or fluid a tumor contains can help doctors determine whether a patient requires a biopsy or surgery. For more information, please visit http://www.mskcc.org/thyroidcancer
12-3 - Jatin P Shah -  Treatment for Differentiated Cancer (Part 3)
 
10:29
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Views: 12623 StatementsCancer
Learn about our approach to thyroid cancer care.
 
02:44
Meet our thyroid cancer specialists and learn about our approach to care. Learn about Thyroid Cancer: https://www.mskcc.org/cancer-care/types/thyroid CONNECT WITH MSK Facebook: http://facebook.com/sloankettering Twitter: http://twitter.com/sloan_kettering Instagram: http://instagram.com/sloankettering Request an appointment at MSK by calling 800-525-2225 or online at: https://www.mskcc.org/appointments/request-appointment
Lymph Nodes in Thyroid Cancer
 
04:47
Experts from MSKCC say that removing suspicious lymph nodes during thyroid cancer surgery may not affect treatment outcomes for most patients.
Papillary Thyroid Cancer - Post 2
 
06:42
My journey through papillary thyroid cancer diagnosis, treatment and recovery to help others in similar situations. This is a post surgery update Quick notes: Day 1- 5 hour plus surgery Day 2- body numb, Meds for pain, throat sore, small memory loss, depleted calcium, Chyle leaks, diet mess up Day 3- Nauseau, intense pain, more calcium supplements, chyle leaks continue, walking around Day 4-pain random, calcium up, leak down Day 5 - pain controlled, calcium up, leak down Day 6 - ready to go home, one more day of observation Day 7- discharged with drain tubes. Light pain in back Day 8 - Leak fully down, intense muscular skeletal spams in back - muscle relaxants Day 9 - all pain down, minor leak Day 10 - drain tubes out. Minor victories like shaving properly, holding kid :) Meds - Muscle relaxants, Pain, Calcium 3 kinds, Thyroid Hormone How am I getting through this- Amazing love from my Wife; Pretty smiles and kisses from my 7 month old; Physical presence and care from Andy, Jeanie, Alison; support from quality colleagues / bosses; a lot of well wishers in my life. Humbled.
Views: 3594 MyCancerJournal
papillary thyroid cancer - post 1
 
06:45
My journey through papillary thyroid cancer diagnosis, treatment and recovery to help others in similar situations
Views: 4238 MyCancerJournal
Papillary and Follicular Thyroid Cancer. When and How To Treat, or Watch and Wait. Dr. Busaidy.
 
59:14
Papillary and Follicular Thyroid Cancer. When and How To Treat, or Watch and Wait. Dr. Busaidy. ThyCa Conference. Naifa L. Busaidy, M.D., Endocrinologist
Thyroid Cancer: NOT the Good Cancer
 
04:47
Thyroid Cancer is NOT the "good cancer." Compiled by Nikki Ferraro, thyroid cancer survivor and founder of Bite Me Cancer www.bitemecancer.org
Views: 36635 Bite Me Cancer
Screening Not Recommended for Thyroid Cancer
 
00:47
Learn about Thyroid Cancer: https://www.mskcc.org/cancer-care/types/thyroid CONNECT WITH MSK Facebook: http://facebook.com/sloankettering Twitter: http://twitter.com/sloan_kettering Instagram: http://instagram.com/sloankettering Request an appointment at MSK by calling 800-525-2225 or online at: https://www.mskcc.org/appointments/request-appointment
Biopsies and Novel Therapies for Thyroid Cancer -- Sloan-Kettering
 
04:31
Radiologist Lucy Hann describes a quick and relatively painless procedure called fine-needle biopsy, which is used to extract thyroid tumor cells for analysis under a microscope. Endocrinologist Michael Tuttle describes new drugs currently in clinical trials that have improved the ability to treat patients with aggressive tumors that are resistant to radioactive iodine therapy. For more information, please visit http://www.mskcc.org/thyroidcancer
Panel Discussion: Surgical Treatment for Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD (ENT)
 
21:00
Panel Discussion: Surgical Treatment for Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD Chairman, Department of Otolaryngology, Rambam HCC, Haifa -- Gideon Bachar, MD Department of Otolaryngology, Rabin Medical Center, Petah Tikva -- Diana Gaitini, MD Director, Ultrasound Unit, Department of Medical Imaging, Rambam HCC, Haifa -- Haitam Nasrallah, MD Institute of Oncology, Rambam HCC, Haifa -- Moshe Shabtai, MD Vice Chairman, Department of Surgery, Head Endocrine Surgery Service, The Chaim Sheba Medical Center, Tel-Hashomer -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA *** מוגש כשירות לציבור הגולשים והגולשות בלבד ואינו מהווה תחליף כלשהו לייעוץ רפואי אישי ופרטני ***
Views: 1212 Rambam Pro
Thyroid Cancers Less Likely To Shorten Lifespan
 
01:44
The word cancer surely strikes fear in anyone who gets that diagnosis. But more and more often researchers are finding many forms of disease are survivable and livable. More than 56,000 Americans will be diagnosed with thyroid cancer this year. And new research gives them new reason to be hopeful. "Unlike some other cancers, say breast cancer, stomach cancer, even ovarian cancer, thyroid cancer, 95 percent of the time, is a very slow growing, very controllable situation," says Dr. Jacob Golderberger, a general surgeon on the medical staff of Lee Memorial Health System. In fact, most people with thyroid cancer will live as long as people who don't have the disease, provided they get proper treatment. "The nice thing about the thyroid growth, even if it is cancer, it's not a very aggressive cancer. And the success rate in treating that is pretty high. It's an 80 to 90 percent cure rate with the surgery," says Dr. Golderberger. Doctors document nodules with ultrasound and biopsy suspicious growths to determine whether it's cancerous. The majority of thyroid cancers are benign. "It's the malignant ones that we have to deal with a more radical approach, and that is you have to remove the whole thyroid. That's a standard of care and you are left with no thyroid at all," says Dr. Golderberger. People can live without a thyroid, but not the thyroid hormone. It's required to manage our metabolism. Without it, patients are dependent on hormone therapy but can still enjoy a good quality of life. "I would say, close to one third of all people in this country are on some kind of a thyroid replacement," says Dr. Golderberger. Only patients with advanced cases, where the cancer had spread to other parts of the body, had a lower chance of long-term survival than the general population. Today improved diagnostics and treatment is making thyroid cancer a livable disease. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we've been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Views: 1183 Lee Health
What does Thyroid Cancer look like?
 
00:16
Here is a short video showing my malignant tumour (Papillary Thyroid Carcinoma) before the surgeons cut it out. The tumour was 6 cm in size and as you will see in the video, not really visible until I swallowed. I am publishing the video to raise awareness of Thyroid Cancer, in the hope that other people with similar lumps on their neck, will see their doctor before it reaches this size. You can see the tumour twice in this video - once each from two different angles. There is a short delay between the two, as I found it difficult to swallow at the time. PLEASE TAKE NOTE: Having a lump similar to this DOES NOT mean you have Cancer. My mother also had a lump the same and hers was NOT Cancerous. The point is... DON'T PANIC, BUT DON'T IGNORE IT. See a doctor and find out.
Views: 10122 Emma MacDonald
Staging Thyroid Cancer and Residual Disease
 
07:59
MSKCC thyroid cancer experts say that additional treatment may not be needed for residual tumors that do not pose a threat to a patient’s health.
Thyroid Cancer Journey Video 2
 
02:52
Hi, my name is Rachel. I have a very recent diagnosis of stage 3 thyroid and lymph node papillary cancer and am pretty damn determined to get through this positively and effectively. I have a ton of life left to live. And if someone someday happens to be dealing with the same bs as me, I thought it would be nice (possibly even helpful) to have some real day to day experiences with it. I have never recorded myself so far, so please accept this apology in advance for how terrible these may be in quality, sound, etc. Anyway, thank you for watching and remember: Life is what you make of it :)
Views: 4040 Rachel Hope Melson
Thyroid Cancer | Dr. Tony Talebi Discusses the Treatment of Papillary Thyroid Cancer
 
50:20
Dr Tony Talebi discusses the treatment of papillary thyroid cancer with Dr. Kim, Assistant professor of medicine at University of Miami and director of thyroid diseases. Dr Talebi is the owner of Miami Hematology and Oncology Associates.
Views: 9075 Tony Talebi
Dr. Sherman on Pazopanib in Anaplastic Thyroid Cancer
 
02:20
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses the treatment of anaplastic thyroid cancer with intensity-modulated radiation therapy (IMRT), paclitaxel, and pazopanib. For more on head and neck cancer: http://www.onclive.com/specialty/head-and-neck
Views: 782 OncLiveTV
12-2 - Jatin P Shah - Treatment for Differentiated Cancer (Part 2)
 
14:51
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Views: 3757 StatementsCancer
Living With Thyroid Cancer: After Surgery Follow-up Care
 
04:02
Surgeons, doctors and professionals discuss the many aspects of thyroid surgery aftercare, including who is involved (it's not just the surgeons!), what to expect as far as after-surgery symptoms to watch for and activities to avoid, and their own personal theories on aftercare best practices. Featuring: David Myssiorek, MD (New York University School of Medicine), R. Michael Tuttle, MD (Memorial Sloan Kettering), Joshua Klopper, MD (University of Colorado).
Living With Thyroid Cancer: There Is No Such Thing As Good Cancer
 
04:11
Cancer. No single word causes greater fear. Upon hearing the words, “You have cancer,” many thyroid cancer patients are told not to worry because they have the “good” cancer. Is it the best practice to tell a patient they have a “good” form of cancer? Patients and professionals discuss the importance of understanding the gravity of their disease, as well as their personal experiences with being diagnosed.
Mechanism-based Therapies for Advanced Thyroid Cancers
 
51:50
A Division of Endocrinology, Diabetes and Bone Diseases Grand Rounds presented by James A. Fagin, MD, Memorial Sloan Kettering Cancer Center
Diagnosing Thyroid Cancer
 
03:28
Radiologist Lucy Hann describes the role of ultrasound in determining whether a thyroid tumor is cancerous or noncancerous.
Dr. Tuttle on Augmenting Pre-Operative Risk of Recurrence Stratification in DTC
 
01:38
R. Michael Tuttle, MD, Memorial Sloan Kettering Cancer Center, discusses a study that looked at augmenting pre-Operative risk of recurrence stratification in differentiated thyroid carcinoma. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 367 Targeted Oncology
Thyroid Cancer Patient Stories
 
01:45
Butterfly Thyroid Cancer Trust is the first charity in the UK to be dedicated solely to the support of patients with thyroid cancer. This short clip provides a brief insight into the experiences of Papillary Thyroid Carcinoma survivors, and is part of a forthcoming thyroid cancer film to be distributed free to all new thyroid cancer patients in the UK. http://www.butterfly.org.uk http://www.euanpreston.com
Views: 11116 ButterflyTCT
Living with Thyroid Cancer: Lori's Story
 
05:47
Lori has been living with thyroid cancer since 2008. In this video she talks about the things that have helped her through her diagnosis along with the many treatments she has undergone. This is an inspiring story of a person's struggle to come to terms with cancer. http://www.streamingwell.com/thyroid-cancer-loris-story-video.html Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe. Find us at: http://www.streamingwell.com Subscribe to Streaming Well: http://www.youtube.com/subscription_center?add_user=StreamingWell Like us on: http://www.facebook.com/StreamingWell Follow us on: http://www.twitter.com/StreamingWell Follow us on: http://www.instagram.com/streamingwell Follow us on: http://pinterest.com/StreamingWell/
Views: 22438 streamingwell
Anaplastic Thyroid Cancer Sosa and Tuttle 07292011
 
01:03:42
Published on Jul 27, 2014 Anaplastic Thyroid Cancer Recorded July 29, 2011 Speakers: Julie Ann Sosa, M.D., M.A. and R. Michael Tuttle, M.D. Julie Ann Sosa, M.D., M.A., is an Endocrine and Oncologic Surgeon and Associate Professor of Surgery at Yale University School of Medicine, New Haven, Connecticut. She is principal investigator or co-principal investigator of studies of new drug treatments for differentiated thyroid cancer (papillary/follicular), medullary thyroid cancer, and anaplastic thyroid cancer. Following undergraduate education at Princeton University, she received a master's degree in Human Sciences at the University of Oxford in the United Kingdom and her medical degree from Johns Hopkins University School of Medicine, Baltimore, Maryland. She received postgraduate training at Johns Hopkins Hospital in Baltimore, Maryland, as well as John Radcliffe and Churchill Hospitals, Oxford, England. She is a frequent invited lecturer and course leader/instructor for professional audiences. She is a member of ThyCa”s Medical Advisory Council. R. Michael Tuttle, M.D. is an endocrinologist at Memorial Sloan-Kettering Cancer Center, New York, New York. He is also Professor of Medicine at the Joan and Sanford I. Weill Medical College of Cornell University in New York, NY. He is an active clinician and researcher specializing in the management of advanced thyroid cancer. He travels extensively both within the US and abroad lecturing on the difficult management issues in thyroid cancer. His research projects in radiation-induced thyroid cancer have taken him from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. He serves on the American Thyroid Association committee that produced the current guidelines for the management of benign and malignant thyroid nodules. He also chaired the National Comprehensive Cancer Network Thyroid Cancer Panel, and served on the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug, and as a consultant. He is a member of ThyCa”s Medical Advisory Council. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa's web site. She also represents ThyCa at medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Papillary Thyroid Cancer - Post3
 
01:51
My Journey through diagnosis, treatment and comeback :)
Views: 894 MyCancerJournal
Thyroid Cancer - The Nebraska Medical Center
 
07:01
Thyroid cancer is one of the most treatable and curable forms of cancer. Dr. Bill Lydiatt, a surgical oncologist and thyroid cancer survivor, explains the symptoms, treatment and why it's important to catch thyroid cancer early. The first sign of a cancer in the thyroid gland is a painless lump in the neck. However, each individual may experience symptoms differently. Other symptoms may include: * hoarseness or loss of voice as the cancer presses on the nerves to the voice box * difficulty swallowing as the cancer presses on the throat For more information or to make an appointment, call 1-800-922-0000 or visit http://www.nebraskamed.com.
Views: 22951 Nebraska Medicine
Thyroid Cancer: Nodules and Diagnosis, including Recurrence. Dr. Haugen. ThyCa Conference
 
01:00:44
Determining a Thyroid Cancer Diagnosis and Diagnosing a Recurrence: Evaluating Nodules. Bryan R. Haugen, M.D., Endocrinologist
Thyroid Cancer Diagnosis
 
01:55
(KUTV) Experts say more cases of thyroid cancer are being diagnosed in the United States.The first symptom is what is called a thyroid nodule. Generally when tests come back inconclusive, doctors have a tough choice to make.Six weeks after giving birth doctors discovered that Aimee Ferrell had a thyroid nodule, which can be a symptom of cancer. Results from a biopsy were inconclusive, traditionally at this stage doctors will perform surgery to remove the thyroid for further testing.Doctor Shahzad Ahmad is a physician at the Thyroid Institute of Utah, instead of performing surgery on patients who have inconclusive thyroid biopsy results, he orders a genome test. In Aimme's case the genome test showed no signs of cancer, she will be tested every 6 months just to make sure no cancerous cells are developing.Doctor Ahmad says about 15 to 30 percent of biopsy results for thyroid cancer come back inconclusive, if doctors perform surgery the patient will need to be on medication for the rest of his or her life.(Copyright 2013 Sinclair Broadcasting Group)
Views: 8348 KUTV2News
Dr. Sherman on Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
 
01:30
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses a pilot study of selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. More on head and neck cancer: http://www.onclive.com/specialty/head-and-neck
Views: 238 OncLiveTV
Dr. R. Michael Tuttle on New Horizons for Radioactive Iodine Treatment
 
01:37
R. Michael Tuttle, MD, professor of Medicine, Memorial Sloan Kettering Cancer Center talks about the new horizons for radioactive iodine treatment in thyroid cancer. He says some new treatments, like the MAP kinase inhibitor and BRAF inhibitor, block pathways that would allow a cancerous thyroid tumor to concentrate radio iodine. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 325 Targeted Oncology
Dr. Eric Sherman Discusses Vandetanib's Dosage and Precautions
 
01:54
Eric J. Sherman, MD, Head and Neck Oncology, Memorial Sloan-Kettering Cancer Center, discusses two of the leading concerns for the oral kinase inhibitor vandetanib (Caprelsa), an FDA approved treatment for medullary thyroid cancer. Read more at http://www.onclive.com/onclive-tv/Dr-Sherman-on-Vandetanibs-Dosage-and-Precautions
Views: 538 OncLiveTV
Papillary Thyroid Cancer | Symptoms, Treatments, and Prognosis for Papillary Thyroid Cancer
 
01:18
Papillary Thyroid Cancer | Symptoms, Treatments, and Prognosis for Papillary Thyroid Carcinoma, all about Papillary Thyroid Cancer. VISIT: ►►► http://Papillary-ThyroidCancer.com ◄◄◄ http://www.youtube.com/watch?v=eVM4Vs47IW0 Papillary thyroid cancer (also sometimes called papillary thyroid carcinoma) is the most common type of thyroid cancer. You may have even heard your doctor talk about metastatic papillary thyroid cancer ("metastatic" means that it has spread beyond your thyroid gland). This article will focus on papillary thyroid cancer basics, including papillary thyroid cancer symptoms, treatments, and prognosis Papillary thyroid carcinoma is the most common thyroid cancer. About 80% of all thyroid cancers cases are papillary thyroid cancer.1 What are some papillary thyroid cancer signs and symptoms? Papillary carcinoma typically arises as an irregular, solid or cystic mass that comes from otherwise normal thyroid tissue. This cancer has a high cure rate with 10-year survival rates for all patients with papillary thyroid cancer estimated at 80% to 90%. Cervical metastasis (spread to lymph nodes in the neck) are present in 50% of small papillary carcinomas and in more than 75% of the larger papillary thyroid carcinomas. The presence of lymph node metastasis in these cervical areas causes a higher recurrence rate but not a higher mortality rate. Distant metastasis is uncommon, but lung and bone are the most common sites if the papillary carcinoma does spread. Tumors that invade or extend beyond the thyroid capsule have a much worse prognosis because of a high local recurrence rate. But what do doctors look for to diagnose papillary thyroid cancer? Characteristics of Papillary Thyroid Cancer Peak onset ages are 30 to 50 years old. Papillary thyroid cancer is more common in females than in males by a 3:1 ratio. The prognosis directly related to tumor size. (Less than 1.5 cm [1/2 inch] is a good prognosis.) This cancer accounts for 85% of thyroid cancers due to radiation exposure. In more than 50% of cases, it spreads to lymph nodes of the neck. Distant spread (to lungs or bones) is uncommon. The overall cure rate is very high (near 100% for small lesions in young patients). Although survival following papillary thyroid cancer (PTC) is high, a small but significant number of recurrences and deaths occur decades after diagnosis, a long-term study has found. The 3 most commonly cited studies on PTC have median follow-up times of 11, 15, and 15.7 years. In contrast, the new research reports on a median of 27 years of follow-up in a cohort of 269 PTC patients, said Raymon H. Grogan, MD, assistant professor of surgery and director of the endocrine surgery research program at the University of Chicago Medicine, Illinois. He presented the findings this week here at the American Association of Endocrine Surgeons 2013 Annual Meeting. Papillary thyroid cancer (as is the case with follicular thyroid cancer) typically occurs in the middle aged with a peak incidence in the 3rd and 4th decades. It is more common in women with a F:M ratio of 1:1.6 - 3:1 2. Papillary thyroid cancer, which is the most common type of thyroid cancer, makes up about 80% of all cases of thyroid cancer. It is one of the fastest growing cancer types with over 20,000 new cases a year. In fact, it is the 8th most common cancer among women overall and the most common cancer in women younger than 25. Most Patients Survive Papillary Thyroid Cancer Regardless of Treatment According to a study reported on in the May, 2010 issue of the Archives of Otolaryngology-Head & Neck Surgery, papillary thyroid cancer that has not spread outside the thyroid gland has a generally favorable outcome for patients, whether or not they receive treatment within a year of diagnosis. According to the study author, "...nearly every thyroid gland might be found to have a cancer if examined closely enough. The advent of ultrasonography and fine-needle aspiration biopsy has allowed many previously undetected cancers to be identified, changing the epidemiology of the disease. Over the past 30 years, the detected incidence of thyroid cancer has increased three-fold, the entire increase attributable to papillary thyroid cancer and 87% of the increase attributable to tumors measuring less than 2 centimeters." Although survival following papillary thyroid cancer (PTC) is high, a small but significant number of recurrences and deaths occur decades after diagnosis, a long-term study has found. "Papillary thyroid cancer in general has a very good prognosis... Also, papillary thyroid cancer rates have been rising steadily for several decades worldwide. The combination of these 2 factors means that more and more people will be living with [the diagnosis] for several decades. This is why we think our study is important," Dr. Grogan told Medscape Medical News. Papillary Thyroid Cancer http://www.youtube.com/PapillaryThyroidCanc . .
Recurrence of a papillary carcinoma of the thyroid. Lymph nodes in the neck - case 14
 
00:41
Complete case history on http://www.thyrosite.com/thyroid/1277/index.htm
Views: 526 Tamas Solymosi
Thyroid Cancer Journey Video 1 5-5-2013
 
06:46
Hi, my name is Rachel. I have a very recent diagnosis of stage 3 thyroid and lymph node papillary cancer and am pretty damn determined to get through this positively and effectively. I have a ton of life left to live. And if someone someday happens to be dealing with the same bs as me, I thought it would be nice (possibly even helpful) to have some real day to day experiences with it. I have never recorded myself so far, so please accept this apology in advance for how terrible these may be in quality, sound, etc. Anyway, thank you for watching and remember: Life is what you make of it :)
Views: 7495 Rachel Hope Melson
Case Study: Treating Papillary Thyroid Cancer
 
05:12
Marcia S. Brose, MD, PhD, presents a case study focused on a women diagnosed with papillary thyroid cancer at age 35 who went on to receive systemic therapy. For more from this discussion, visit http://www.onclive.com/peer-exchange/thyroid-cancer
Views: 2662 OncLiveTV
Thyroid Cancer Needle Aspiration #1
 
09:48
This was my first step with Thyroid Cancer, Biopsy.
Views: 15035 M Houteee
How Many Lymph Nodes Do You Have In Your Neck?
 
01:00
Of the 800 lymph nodes in human body, 300 are neck. It is done in the hospital. The lymph nodes beneath and of the papillary thyroid cancer. Swollen lymph nodes pain in neck, groin, armpit, ear, causes how many are the neck? Quora. Mysticdoc yes, this is correct. Metastatic lymph nodes are those that have cancer cells in them (spread from a primary tumor somewhere else). Examining your the nodes around collarbone and neck (supraclavicular, infraclavicular, cervical nodes) are examined manually (by hand) there many different types of cancer that can grow anywhere in body. Memorial sloan kettering. That combines many x ray images with the aid of a computer to generate cross sectional and three dimensional 800 lymph nodes in human body, 300 are neck. Sometimes, your surgeon can tell which. For instance, ear pain, fever, and enlarged lymph nodes near your are clues that you may have an infection or cold. If a person has symptoms of cold or other minor infection for which they may not take antibiotics, it takes about two weeks the nodes to return normal size example, lymph node in underarm (axilla) can compress blood vessels and nerves supplying arm. They function as part of the immune system and harbour lymphocytes that act against infections or foreign bodies. Lymph nodes are small bean shaped glands that we have throughout our bodies including the head and neck area. The type you will have depends on where the cancer is, whether it has spread to your lymph nodes, and other structures in neck. The amount of tissue and the number lymph nodes that are removed depend on how far to check. About your neck dissection surgery. Lymph nodes cancer staging & treatment options lymph node removal news medical. However when affected by an infection or cancer they may get bigger at the neck 14 feb 2017 if you have invasive breast cancer, your surgeon will probably remove some of lymph nodes under arm during lumpectomy mastectomy. Mysticdoc there can be some variability 29 aug 2012 for example, if a patient has small cancer completely removed and all of the nodes are free cancer, might not any need further treatment anatomists tell us that 100 to 200 lymph in neck, so even with more comprehensive neck dissection, we removing only how do you know have swollen nodes? The ones most frequently enlarged or found (a chain is located front sides many people acute hiv infection symptoms signs until they infected virus cervical. Depending on the cause of your swollen lymph nodes, other signs and symptoms you might have include nodes self care at home. Lymph node removal for invasive breast cancer metastatic lymph nodes head and neck info teens. They are often the first place cancer cells spread to when they break away from a 29 aug 2017. If nearby or distant nodes show cancer, the n is assigned a number (such as 1, 2 3), depending on how many are affected, much cancer in them, large they are, and 27 jun 2012 lymph filters located at intervals between channels. Normally the
Views: 39 new sparky
Thyroid Cancer: Lymph Node Evaluation & Mapping, Pre- & Post-Operative. Dr. Patel. ThyCa Conference
 
01:04:35
A Discussion of Lymph Node Evaluation in the Setting of Thyroid Cancer: Pre- and Post-Operative Nodal Mapping and Assessment. Nayana Patel, M.D., Radiologist